Cargando…

Luminal Breast Cancer Cell Lines Overexpressing ZNF703 Are Resistant to Tamoxifen through Activation of Akt/mTOR Signaling

BACKGROUND: Selective estrogen receptor modulators, such as tamoxifen, play a pivotal role in the treatment of luminal-type breast cancer. However, in clinical applications, nearly half of breast cancer patients are insensitive to tamoxifen, a small number of whom have early recurrence or disease pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xi, Mu, Xin, Huang, Ou, Xie, Zuoquan, Jiang, Min, Geng, Meiyu, Shen, Kunwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753350/ https://www.ncbi.nlm.nih.gov/pubmed/23991038 http://dx.doi.org/10.1371/journal.pone.0072053

Ejemplares similares

Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
por: Jiang, Min, et al.
Publicado: (2013)

ZNF703 gene amplification at 8p12 specifies luminal B breast cancer
por: Sircoulomb, Fabrice, et al.
Publicado: (2011)

ZNF703 gene amplification at 8p12 specifies luminal B breast cancer
por: Sircoulomb, Fabrice, et al.
Publicado: (2011)

Overexpression of ZNF703 facilitates tumorigenesis and predicts unfavorable prognosis in patients with cholangiocarcinoma
por: Li, Keyu, et al.
Publicado: (2016)

Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors
por: Bazarov, Alexey V, et al.
Publicado: (2011)

MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR Pathway
por: Guo, Jingyun, et al.
Publicado: (2021)

ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium
por: Holland, Daniel G, et al.
Publicado: (2011)

Insights into the pleiotropic roles of ZNF703 in cancer
por: Wang, Shuang, et al.
Publicado: (2023)

ZNF703 Overexpression may act as an oncogene in non‐small cell lung cancer
por: Baykara, Onur, et al.
Publicado: (2016)

High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer
por: Reynisdottir, Inga, et al.
Publicado: (2013)

ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis
por: Zhang, Xi, et al.
Publicado: (2022)

Nlz1/Znf703 acts as a repressor of transcription
por: Nakamura, Mako, et al.
Publicado: (2008)

Znf703 is a novel RA target in the neural plate border
por: Janesick, Amanda, et al.
Publicado: (2019)

ZNF488 Promotes the Invasion and Migration of Pancreatic Carcinoma Cells through the Akt/mTOR Pathway
por: Qiu, Hongquan, et al.
Publicado: (2022)

Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit
por: Bostner, Josefine, et al.
Publicado: (2012)

Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy
por: Wang, Hufei, et al.
Publicado: (2023)

LINC00460 accelerates progression of ovarian cancer by activating transcriptional factor ZNF703
por: Wang, Xin, et al.
Publicado: (2020)

Retracted: ZNF488 Promotes the Invasion and Migration of Pancreatic Carcinoma Cells through the Akt/mTOR Pathway
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines
por: Udu-Ituma, Sandra, et al.
Publicado: (2023)

Apoptotic Effects of Linum album Extracts on AGS Human Gastric Adenocarcinoma Cells and ZNF703 Oncogene Expression
por: Asl, Elham Akbari, et al.
Publicado: (2018)

ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15
por: Wang, Shuang, et al.
Publicado: (2020)

The Paradox of Akt-mTOR Interactions
por: Vadlakonda, Lakshmipathi, et al.
Publicado: (2013)

Memorandum 703
por: Mallot, Gerhard k, et al.
Publicado: (2003)

(703) WITHDRAWN
Publicado: (2023)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

PODNL1 promotes cell proliferation and migration in glioma via regulating Akt/mTOR pathway
por: Geng, Yibo, et al.
Publicado: (2020)

Elevated ZNF704 expression is associated with poor prognosis of uveal melanoma and promotes cancer cell growth by regulating AKT/mTOR signaling
por: Luo, Jingting, et al.
Publicado: (2023)

EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling
por: Cheng, Dong-dong, et al.
Publicado: (2018)

Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines
por: Li, Fahong, et al.
Publicado: (2022)

Overexpression of Renin-B Induces Warburg-like Effects That Are Associated with Increased AKT/mTOR Signaling
por: Golchert, Janine, et al.
Publicado: (2022)

Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma
por: Yang, Hang, et al.
Publicado: (2015)

The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression
por: Shi, Yongguo, et al.
Publicado: (2015)

Overexpression of ribonuclease inhibitor induces autophagy in human colorectal cancer cells via the Akt/mTOR/ULK1 pathway
por: Tang, Ying, et al.
Publicado: (2019)

Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway
por: Gao, Shangfeng, et al.
Publicado: (2017)

Overexpression of Notch2 enhances radiosensitivity via inhibition of the AKT/mTOR signaling pathway in nasopharyngeal carcinoma
por: Wu, Li-Zhi, et al.
Publicado: (2021)

Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer
por: Abdel-Hafiz, Hany A.
Publicado: (2017)

Akt and mTOR in B Cell Activation and Differentiation
por: Limon, Jose J., et al.
Publicado: (2012)

Akt and mTOR mediate programmed necrosis in neurons
por: Liu, Q, et al.
Publicado: (2014)

Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells
por: Woo, Yu Mi, et al.
Publicado: (2015)

Depletion of Luminal Pyridine Nucleotides in the Endoplasmic Reticulum Activates Autophagy with the Involvement of mTOR Pathway
por: Kapuy, Orsolya, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kj4u2flg3haonlbiqgkkv4gfpg